| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.5 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.5 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |